Most read articles by the same author(s)

• Muriel Kruijver, Philip Bruggmann, Raphael Magnolini, Evidence of use and users of image- and performance-enhancing drugs in sports in Switzerland: a scoping literature review and implications for Swiss drug policy , Swiss Medical Weekly: Vol. 153 No. 5 (2023)
• Elke Lauber, Annette Kindlimann, Dunja Nicca, Renate Altermatt-von Arb, Corina Sgier, Sandra Staudacher, Monique Sailer Schramm, Franziska Vökt, Franziska Zúñiga, Integration of an advanced practice nurse into a primary care practice: a qualitative analysis of experiences with changes in general practitioner professional roles in a Swiss multiprofessional primary care practice , Swiss Medical Weekly: Vol. 152 No. 2526 (2022)
• Francesco Negro, Beat Müllhaupt, David Semela, Sarah Blach, Philip Bruggmann, Andrea De Gottardi, Jean-Francois Dufour, Montserrat Fraga, Antonio Galante, Homie Razavi, Joana Vieira Barbosa, Devin Razavi-Shearer, The current and future burden of hepatitis B in Switzerland: a modelling study , Swiss Medical Weekly: Vol. 153 No. 6 (2023)
• Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, Muriel Kruijver, Philip Bruggmann, Oliver Senn, Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study , Swiss Medical Weekly: Vol. 155 No. 2 (2025)
• Babette L. Winter, Frédérique Hovaguimian, Roger D. Kouyos, Axel Jeremias Schmidt, Enos Bernasconi, Dominique L. Braun, Alexandra Calmy, Julia Notter, Marcel Stoeckle, Bernard Surial, Vanessa Christinet, Matthias Cavassini, Carsten Depmeier, Severin Läuchli, Emmanuelle Boffi El Amari, Matthias Reinacher, Manuela Rasi, Philip Bruggmann, David Haerry, Raphaël Bize, Nicola Low, Andreas Lehner, Boris B. Quednow, Jan S. Fehr, Benjamin Hampel, Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study , Swiss Medical Weekly: Vol. 152 No. 2526 (2022)
• Philip Bruggmann, Eliminating viral hepatitis B and C in times of war and increasing global refugee crisis , Swiss Medical Weekly: Vol. 153 No. 4 (2023)
• Rosario Agosti-Gonzalez, Luis Falcato, Thomas Grischott, Oliver Senn, Philip Bruggmann, Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study , Swiss Medical Weekly: Vol. 153 No. 6 (2023)
• Rainer Fretz, Francesco Negro, Philip Bruggmann, Daniel Lavanchy, Andrea De Gottardi, Isabelle Pache, Virginie Masserey Spicher, Andreas Cerny, Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)
• Eleni Moschouri, Gloria Salemme, Adriana Baserga, Andreas Cerny, Ansgar Deibel, Beat Müllhaupt, Marie-Anne Meier, Christine Bernsmeier, Marie Ongaro, Francesco Negro, Marielle Grosjean, Olivier Clerc, Patrizia Künzler-Heule, David Semela, Gabriel Hobi, Felix Stickel, Adeline Mathieu, Elise Mdawar-Bailly, Mohamed Faouzi, Darius Moradpour, Montserrat Fraga, Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis , Swiss Medical Weekly: Vol. 154 No. 6 (2024)
• Philip Bruggmann, Oliver Senn, Anja Frei, Milo A. Puhan, Jan Fehr, Luis Falcato, High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study , Swiss Medical Weekly: Vol. 152 No. 0102 (2022)